Navigation Links
Biotechnology Reagents Market by Technology, Applications and End-Users - Current Trends, Opportunities and Global Forecasts to 2016
Date:4/30/2013

DUBLIN, April 30, 2013 /PRNewswire/ --

Research and Markets announces the addition of "Biotechnology Reagents Market by Technology, Applications and End-Users - Current Trends, Opportunities and Global Forecasts to 2016" to its catalogue.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The biotechnology reagent market is vast; it consists of several technologies such as PCR, cell culture, IVD, expression and transfection, chromatography, spectrometry, electrophoresis, and flow cytometry. This report studies the biotechnology reagents market, by technology, end-users, and applications. The biotechnology reagents market, by technology studied in this report are segmented as life science reagents and analytical reagents; of which life science segment accounted for the largest share of 59.37% of the total market in 2011. The global biotechnology reagents market was valued at $40.3 billion in 2011 and is expected to reach $59.3 billion by 2016; growing at a CAGR of 8% from 2011 to 2016.

The biotechnology reagents market is driven by the increasing use of reagents in therapeutics, basic research and commercial applications. The demand for biotechnology reagents is mainly dependent upon the growth of the biotechnology instrumentation market. The biotechnology instrumentation market continues to witness significant growth due to an increase in the number of biotechnology firms around the globe and increase in research and development expenditure by the biotechnology companies, thus augmenting the demand for biotechnology instruments. Continual product developments are being witnessed in various industries, such as pharmaceutical/bio-pharmaceutical, agri-biotech, and food and beverages; this is expected to facilitate market growth.

North America dominated the biotechnology reagents market with 46.28% share in 2011. Successful completion of the first phase of the Human Genome Project, ahead of schedule, has given rise in the U.S. reagent market. Investments, government funding, and new products are driving the reagents market in the U.S. The Asian market, however, shows greater opportunities, when compared to other regions, with the highest CAGR of 11.8% from 2011 to 2016; due to increased research outsourcing activities in the life technology field.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Life Sciences & Analytical Reagents Market, By Technology

5 Global Life Science & Analytical Reagents Market, By Applications

6 Geographical Analysis

7 Competitive Landscape

8 Company Profiles


Companies Mentioned

- Abbott Laboratories

- Agilent Technologies Inc.

- Beckman Coulter Inc.

- Becton, Dickinson And Company (Bd)

- Biomerieux

- Bio-Rad Laboratories Inc.

- Ge Healthcare

- Hoefer Inc.

- Life Technologies Corporation

- Lonza Group Ltd.

- Meridian Biosciences Inc.

- Merck Millipore

- Perkinelmer

- Promega Corporation

- Quality Biological Inc.

- Roche Diagnostics Limited

- Siemens Healthcare

- Sigma Aldrich Corporation

- Strategic Diagnostics Inc. (Sdix)

- Sysmex Corporation

- Takara Bio Inc.

- Techne Corporation

- Thermo Fisher Scientific Inc.

- Tosoh Corporation

- Waters Corporation

- W.R. Grace & Co.

For more information please visit Research and Markets.

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contact Details

Research and Markets
Laura Wood , Senior Manager.
press(at)researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Biotechnology



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Goodwin Biotechnology and Coldstream Laboratories Announce a Collaboration to Develop and Manufacture Cytotoxic Antibody Drug Conjugates
2. Lixte Biotechnology Announces Initiation Of A Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100
3. Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development
4. Plandai Biotechnology, Inc. Announces Shipment Of First Machinery To South African Production Facility
5. PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs
6. Choose New Jersey and Partners to Promote New Jersey As Global Life Science Hub at Worlds Largest Biotechnology Event
7. Plandai Biotechnology, Inc. Enters Into License Agreement With Phyto Nutricare To Develop Nutraceutical Products
8. Biotechnology Market (Biopharmacy, Bioservices, Bioagri, Bioindustrial) Is Expected to Reach USD 414.5 Billion Globally in 2017: Transparency Market Research
9. NanoSight, One of the UKs Fastest Growing Biotechnology Companies, Wins a 2013 Queens Award for Enterprise - Innovation
10. Global Biotechnology Industry Market Research Report Now Available from IBISWorld
11. Plandai Biotechnology, Inc. Updates Progress Of Preparing Products For Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... Band-LOK, LLC, ... announced today that two new patents have been allowed by the USPTO on ... Band-LOK, said, “We continue to explore additional clinically-relevant designs for both the implants ...
(Date:9/18/2017)... , a growing leader in Electronic Trial Master file solutions ... research organization, Multidisciplinary Association for Psychedelic Studies (MAPS). ... MAPS Public Benefit Corporation selects ... ... for the treatment of Posttraumatic Stress Disorder (PTSD). MAPS also reached ...
(Date:9/15/2017)... San Diego, CA (PRWEB) , ... September 15, ... ... manufacturer Grolltex, has recently closed what it calls an ‘Internal Seed B’ round ... of the company’s stock and was completed using a ‘SAFE’ documentation structure at ...
(Date:9/14/2017)... Frederick, Maryland (PRWEB) , ... ... ... today, proudly announces the launch of its CliniControl™ (CC) product portfolio, clinically-relevant ... manufacturing, accelerating clinical translation of human Mesenchymal Stem/Stromal Cell (hMSC)-based therapies. The ...
Breaking Biology Technology:
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):